Westlake Corporation has reported its fourth quarter and full year 2024 financial results, revealing a GAAP earnings per share (EPS) of $0.43, which exceeded analysts' expectations of $0.36. The company reported sales of $290.06 million, surpassing the estimated $262.00 million. However, Westlake's other segment, Westlake Chemical, reported an adjusted EPS of $0.06, which fell short of the forecasted $1.09. Additionally, its revenue of $2.84 billion missed the $2.94 billion estimate, reflecting a year-over-year increase of 0.60%. The non-GAAP EPS also missed expectations by $1.11, indicating a significant decline of 91.67% year-over-year. The company’s stock was down 3.6% in pre-market trading following the announcement.